Article
02-7160FOR THE SECOND CIRCUIT
On behalf of herself and all others similarly situated,
Plaintiff-Appelllee,
Plaintiff-Intervenor-Appellee,
AND MENTAL HEALTH SERVICES, and SUSAN BESIO in her capacity as
Commissioner of the Vermont Department of Developmental and Mental Health Services
Defendants-Appellants.
for the District of Vermont
BRIEF FOR NATIONAL ASSOCIATION OF PROTECTION AND ADVOCACY SYSTEMS, THE JUDGE DAVID BAZELON CENTER FOR MENTAL HEALTH LAW AND NATIONAL ASSOCIATION OF RIGHTS PROTECTION AND ADVOCACY AS AMICI CURIAE IN SUPPORT OF THE APPELLEE AND FOR AFFIRMANCE
Susan Stefan
Robert D. Fleischner
Center for Public Representation
22 Green Street
Northampton, MA 01060
413-586-6024
Counsel for Amici Curiae
July 2, 2002
Corporate Disclosure Statement
__________________________
Robert D. Fleischner
TABLE OF AUTHORITIES iii
INTEREST OF AMICI 1
SUMMARY OF ARGUMENT 3
ARGUMENT 7
I. Persons Subject To Act 114 Are Qualified
To Have Their DPOAs Honored 7
II. Enactments Such As Act 114 That Facially Restrict
On The Basis Of Commitment Status Violate the ADA 9
A. Enactments Such as Act 114 that Facially
Restrict Statutory Rights on the Basis of
Commitment Status Violate the ADA 9
B. Statutes Which Restricted Basic Rights on
the Basis of Commitment or Guardianship
Status Have Consistently Been Invalidated 14
III. Appellants' Fundamental Alteration Defense Fails 18
A. The Affirmative Defense of Fundamental
Alteration Is Inapplicable in Cases Where
the Plaintiff Does Not Seek a Reasonable
Accommodation 18
B. Even if the State Is Entitled to Assert
a Fundamental Alteration or Necessity
Defense, It Cannot Carry Its Burden of
Proof Because There Is No Evidence Linking
Treatment Refusals Under DPOAs to Increased
Lengths of Stay in Hospital Settings 21
CONCLUSION 28
TABLE OF AUTHORITIES
CASES
Allen v. Heckler, 780 F.2d 64 (D.C. Cir. 1985) 14
Bangerter v. Orem, 46 F.3d 1491 (10th Cir. 1995) 14, 20
Borkowski v. Central Valley School District, 63 F.3d 131
(2nd Cir. 1995) 19
Bragdon v. Abbott, 524 U.S. 624 (1998) 21
Doe v. Stincer, 990 F.Supp 1427 (S.D.Fla. 1997), vacated on
other grounds,175 F.3d 879 (11th Cir. 1999) 10, 15, 16
Doe v. Rowe, 156 F.Supp.2d 35 (D.Me. 2001) 14
Ellen S. v. Florida Board of Bar Examiners, 859 F.Supp. 1489
(S.D.Fla. 1994) 17
Garcia v. State of New York Health Sciences Center, 280 F.3d 98
(2nd Cir. 2001) 6, 19
Garrity v. Gallen, 522 F. Supp 171, (D.N.H. 1981) 10
Guckenberger v. Boston University, 947 F.Supp. 106 (D.Mass. 1997) 17
In re Hatsuye T., 689 N.E.2d 248 (Ill. App. Div. 1997) 16
In re Janet S., 712 N.E. 2d 422 (Ill. App.Ct. 1999) 16
In re L.R., 146 Vt. 17 (1985) 11, 12
In re P.S., 167 Vt. 63 (1997) 9, 11, 12
In re Rosa M., 155 Misc.2d 103 (N.Y.Sup.Ct. 19991) 11, 16
J.S. v. City of Newark, 652 A.2d 265 (N.J. Super. 1993) 27
Manhattan State Citizens' Group v. Bass, 524 F.Supp. 1270
(S.D.N.Y. 1981) 14
Martin v. Voinovich, 840 F.Supp. 1175 (S.D. Ohio 1993) 10
Messier v. Southbury Training School, 1999 U.S. Dist. Lexis 1479
(D. Conn. Jan. 5, 1999) 10
Mx. Group v. City of Covington, 2002 U.S.App Lexis 11249
(6th Cir. June 12, 2002) 16, 20
Olmstead v. L.D. ex rel. Zimring, 527 U.S. 581 (1999) 9
Regional Economic Community Action Program v. City of Middletown,
281 F.3d 333 (2nd Cir 2002) 17
Rivers v. Katz, 495 NE2d 337 (N.Y. 1986) 23
Rogers v. Commissioner of Mental Health, 458 NE2d 308 (Mass. 1983) 23, 27
Rogers v. Okin, 478 F.Supp. 1242 (D.Mass. 1979) 23
Staron v. McDonald's Corp., 51 F.3d 353 (2nd Cir. 1995) 19
State ex. rel. Jones v. Gerhardstein, 416 N.W. 2d 883 (Wisc. 1987) 23
Toraty v. Mental Hygiene Legal Services, (In re Joseph O.)
666 N.Y.S.2d 322 (N.Y.App.Div. 1997) 27
United Auto Workers v. Johnson Controls, 499 U.S. 187 (1991) 21
STATUTES, REGULATIONS AND RULES
42 U.S.C. § 10801 1
42 U.S.C. § 12102(a)(5) 3
42 U.S.C. §12131(2) 8, 10, 16
Section 504 of the Rehabilitation Act 10, 15
28 C.F.R. § 35.130(b)(7) 19
14 V.S.A. 3451 3, 5, 6, 13
14 V.S.A. 3452(5) 3
14 V.S.A. 3466 22
18 V.S.A. 1058 13
18 V.S.A. 7624(a)(2) 22
18 V.S.A. 7626 (“Act 114”) passim
18 V.S.A. 7627(d) 8
18 V.S.A. 8401-8402 13
18 V.S.A. 8839 13
ARTICLES AND BOOKS
Appelbaum, Paul S., Gutheil, "Drug Refusal: A Study of Psychiatric
Inpatients," 137 Am.J. Psychiatry 340 (1980) 23
Appelbaum, Paul S., Grisso, "The MacArthur Treatment Competence
Student: I. Mental Illness and Competence to Consent to Treatment,"
19 L. and Human Behavior 105 (1995) 16
Backler, Patricia, McFarland, “A Survey on the Use of Advance
Directives for Mental Health Treatment in Oregon,” 47 Psychiatric
Services 1387 (1996) 16
Bloom, J.D., Williams, Land, et al., "Treatment Refusal Procedures
and Service Utilization: A Comparison of Involuntarily Hospitalized
Populations," 25 J. of the Am. Acad. of Psychiatry and L. 349 (1997) 24
Clayton, Ellen Wright, "From Rogers to Rivers: The Rights of the
Mentally Ill to Refuse Medication," 13 American J. of L. and
Medicine 7 (1987) 24
Cournos, F., McKinnon, Stanley, "Outcome of Involuntary Medication in
a State Hospital System," 148 Am. J. of Psychiatry 489 (1991) 24, 25
Gordon, Phil, "Psychiatric Treatment Refusal, Patient Competence
and Informed Consent," 8 Int'l J. of Psychiatry and Law 83 (1986) 23
Hassenfeld, Irwin, Grumet, "A Study of the Right to Refuse Treatment,"
12 Bulletin of the American Academy of Psychiatry and Law 65 (1984) 24
Kasper, J.A., Hoge, Feucht-Haviar, Cortina, et al., "Prospective Study
of Patients' Refusal of Antipsychotic Medication Under a Physician
Discretion Review Procedure," 154 Am. J. of Psychiatry (1997) 25
Levin, Shelly, et al., "A Controlled Comparison of Involuntarily
Hospitalized Medicaton Refusers and Acceptors," 19 Bul. of the Am.
Acad. of Psychiatry and L. 161 (1991) 24
Rodenhauser, P., Schwenker, Khamis, "Factors Related to Drug
Treatment Refusal in a Forensic Hospital," 38 Hospital and
Community Psychiatry 631 (1987) 24, 25
Williams, et al., "Drug Treatment Refusal and Length of
Hospitalization of Insanity Acquittees," 16 Am. Aca. of
Psychiatry and L. 279 (1988) 24
Zito, Julie, et al., "Drug Treatment Refusal, Diagnosis,
and Length of Hopitalization in Involuntary Psychiatric
Patients," 4 Behavioral Science and the Law 327 (1986) 24
The three organizations submitting this brief are national organizations that advocate for individuals with disabilities. This case involves the scope and interpretation of the Americans with Disabilities Act (“ADA”), which protects people with disabilities against discrimination, as it applies to advance directives for mental health care. Because individuals served by or members of these organizations have encountered discrimination in government programs, amici have an interest in this Court's decision, and particularly the impact it will have on the availability of advance directives as an effective tool for mental health treatment planning. Amici have substantial expertise with regard to the interpretation and application of the laws relevant to this case. The Appellants have consented to the filing of the brief.
The National Association of Protection and Advocacy Systems (“NAPAS”), founded in 1981, is the membership association for protection and advocacy ("P&A") agencies. P&As were established in each state under the Protection and Advocacy for Individuals with Mental Illness Act (hereinafter "PAIMI" or "the Act"), 42 U.S.C. § 10801 et seq., and related federal statutes, to investigate abuse and neglect of persons with mental illness and other disabilities, and to provide them legal representation and advocacy services. In fiscal year 2001 alone, P&As served hundreds of thousands of people with disabilities.
The Judge David Bazelon Center for Mental Health Law (“Bazelon Center”) is a national legal-advocacy organization that works to advance the rights and dignity of individuals with mental disabilities and ensure their equal access to the services and supports they need for full participation in community life. Through litigation and in the public-policy arena, the Center strives to ensure that people with mental disabilities have equal access to health and mental health care, education, housing and employment.
The National Association for Rights Protection and Advocacy (“NARPA”) is an organization comprised of attorneys, lay advocates, people with psychiatric histories, mental health professionals and administrators, and academics. Its fundamental mission for over twenty years has been empowerment, self-determination and equal citizenship of people diagnosed or perceived as psychiatrically or mentally disabled. NARPA’s work includes education, training, and legal intervention, monitoring developing trends in mental health law, and identifying systemic issues and alternative strategies in mental health service delivery. Some of its members have advance directives or durable powers of attorney, and other members are health care agents for people with psychiatric disabilities.
In 1987, Vermont enacted legislation which allowed all Vermont citizens to create durable powers of attorney for health care (“DPOAs”) in order “to enable adults to retain control over their own medical care during periods of incapacity through the prior designation of an individual to make health care decisions on their behalf.” 14 V.S.A. 3451. The statute contemplated that “health care decisions” would include “consent, refusal to consent, or withdrawal of consent to any care, treatment service or procedure to maintain, diagnose or treat an individual’s physical or mental condition.” 14 V.S.A. 3452(5).
Eleven years later, new legislation significantly restricted the right to implement DPOAs for three groups: people involuntarily committed to psychiatric hospitals, people involuntarily committed to the community who had previously been committed to psychiatric hospitals, and convicted felons receiving mental health treatment under the joint custody of the Department of Corrections and the Department of Developmental and Mental Health Services, 18 V.S.A. 7626 (“Act 114”).
Act 114 nullifies the right of individuals subject to it—all of whom are individuals with psychiatric disabilities, and many of whom live in the community--to have their DPOAs implemented in the same way as all other Vermont citizens. People with psychiatric disabilities in Vermont have also been deterred from executing DPOAs because of Act 114. See Affidavit of Judith Rex, Paragraphs 12-21, Joint Appendix at 0215-0216. Making a DPOA’s validity contingent on the clinical improvement of its author is not a requirement imposed on any other citizen or group of citizens in Vermont.
The fact that Act 114 permits this intrusion is ironic, since the very purpose of the DPOA legislation is to “enable adults to retain control over their own medical care during periods of incapacity.” 14 V.S.A. 3451. The benefit of the DPOA legislation, which permits Vermont citizens to effectuate personal values that may matter more than “clinical improvement,” should not be denied to appellees on the basis of their mental disability. This is particularly true when the same statute permits those subject to Act 114 to make treatment choices as long as they are competent, regardless of whether such choices result in “clinical improvement.” It is difficult to understand why appellants permit a competent person to make treatment choices, but preclude him or her from memorializing those choices in a DPOA and effectuating them through the appointment of an agent.
Appellants claim that it would “fundamentally alter” the mental health treatment program if they were required to follow the legal mandate of 14 V.S.A. 3451 et seq. and honor the decisions of health care agents relating to mental health treatment. However, the fundamental alteration defense is not applicable, since appellees are not asking for a reasonable modification of neutral practices, but rather seeking to strike down a facially discriminatory statutory provision. Even if the fundamental alteration defense is applicable, the State has not met its burden of proving that the operation of mental health DPOAs would fundamentally alter the purpose of its program. Rather, DPOAs appear to advance the purpose of the program, which is “to empower [clients] to live as independently and productively as possible.” State of Vermont, Department of Developmental and Mental Health Services Home Page, <http://www.state.vt.us/dmh.> Further, “[t]he goal of the Department of Developmental and Mental Health Services is to have a service system without coercion.” Joint Appendix, A-0185. Honoring DPOAs appears to fit well into the program, rather than to fundamentally alter it.
Appellants’ also argue that honoring DPOAs will result in longer institutional stays. Appellants’ Brief at 18, 39, 43 and 47. They have not presented sufficient evidence to show this. Even if it were true, it is not at all clear how many more days a “longer” stay entails, or that honoring DPOA refusal constitutes a “fundamental alteration” when the mental health system is already required to honor the competent medication refusals of its clients. 18 V.S.A. 7627(d).
The appellants argue that “a person subject to Act 114 is not a qualified individual with a disability” because he or she have been committed for treatment of a mental illness “based on a finding of dangerousness and…[is] incompetent to make treatment decisions.” Appellants’ Brief at 24. The definition of a “qualified individual with a disability” is “an individual with a disability who, with or without reasonable modifications to rules, policies, or practices…meets the essential eligibility requirements for the receipt of services or the participation in programs or activities provided by a public entity.” 42 U.S.C. § 12131(2). The eligibility requirements for implementing and executing a DPOA are contained in the statute, and by its terms it does not exclude people in appellees’ situation.
Under Vermont law, including Act 114, commitment status alone neither empowers the State to medicate an individual against his or her will nor precludes the execution of a DPOA. Involuntary medication of persons subject to Act 114 is precluded if a court finds that they are competent. 18 V.S.A. 7627(d). If commitment status alone does not disqualify an individual from the right to refuse psychotropic medication, or from executing a DPOA, it is difficult to see how commitment status plus incompetence would disqualify an individual from implementation of a DPOA since being incompetent is a necessary qualification for its implementation. It makes very little sense to give competent psychiatric patients—even committed ones—the right to refuse psychotropic medication, but to deny them the right to implementation of their DPOAs. The State’s arguments about commitment, dangerousness, and custody are just as applicable to competent individuals under orders of treatment, and yet they have the right to refuse medication.
Finally, it is clear that if a person is presently assaultive or threatening assault or to harm him or herself, the DPOA would not preclude emergency intervention. Appellees have never contested this. Medication used to prevent imminent harm is not the same as the ongoing medication for treatment covered by a DPOA. Since a committing court need only find dangerousness on a person’s first commitment, In re P.S. 167 Vt. 63, 71 (1997), and individuals can be recommitted many times, the appellants’ argument that all persons subject to Act 114 are unqualified because they are presently dangerous is incorrect. An initial finding of dangerousness—perhaps years earlier—is not sufficient to disqualify an individual from the right to have a DPOA implemented years after the initial commitment.
II. Enactments Such as Act 114 that Facially Restrict Statutory Rights on the Basis of Commitment Status Violate the ADA
Although people subject to Act 114 are disabled, otherwise qualified to implement DPOAs, and singled out as a group for differential and adverse limitations on their DPOAs, appellants argue that they are not discriminated against because of their mental illness. Rather, appellants contend their right to have their DPOAs honored is limited because 1) they are either dangerous or substantially likely to become dangerous and 2) they are in state custody. Appellants’ Brief at 20,27,32,34. However, competent persons who are committed and in state custody are allowed to make treatment choices regardless of their clinical improvement. It is difficult to understand a distinction that forbids these same people, while competent, from completing an enforceable written document indicating their treatment choices and appointing an agent. As the court said in In re Rosa M., the first case involving the advance directive of a hospitalized individual,
The only time that the State actually needs to prove dangerousness is in an individual’s initial commitment. In re P.S., 167 Vt. at 71. Even at the initial commitment hearing, there is no need to show an overt act of dangerousness nor need the act of dangerousness be recent. In re L.R., 146 Vt. 17, 20-22 (1985). In fact, it need not even be “dangerous” under the common understanding of the word: deterioration of mental status is enough for an initial commitment. Id. Thus, while in everyday discourse “dangerousness” connotes credible threats directed at others, in the commitment context it may simply mean that soon the individual will be unable to care for himself or herself. As the Vermont Supreme Court has said, “In this context, dangerousness is an ‘amorphous concept,’ that is highly dependent on its application…many states have defined the concept with no more certainty and imminence than our ‘patient in need of further treatment’ standard…” In re P.S., 167 Vt. at 104-105. Thus, to say that Act 114 applies only to people who are dangerous or substantially likely to become dangerous is simply another way of saying that a certain subset of people with mental illness are singled out by a state statute to be excluded from the benefit of having a DPOA honored for more than 45 days.
The exclusion of Act 114 is not based on any judgment or inquiry as to the competence of such individuals when executing the DPOA. Rather it is based on a disagreement with the choices they may have while competent . People whose DPOAs happen to agree with clinical recommendations will not be subject to Act 114’s restrictions. This is a content-based restriction that nullifies the ability of a competent person with a psychiatric disability, who often has previous experience of treatment and its effects, to make treatment choices while competent and have those choices honored later. Act 114 suspends the operation of a DPOA based on the treatment choice of the individual—the protection of which is the core function of a DPOA.
Finally, the appellant’s distinction that Act 114 discriminates on the basis of dangerousness plus state custody, is dubious. There are a number of groups of people who are dangerous and in state custody, whose rights to full implementation of DPOAs have not been hindered by the State. If the issue is dangerousness and state custody, it is difficult to understand why other people in state custody because of dangerousness have not had their DPOA rights limited. People with untreated tuberculosis, who can be committed to state custody, can execute and implement DPOAs.18 V.S.A. 1058. People with mental retardation who are dangerous can be in state custody, 18 V.S.A. 8839, without losing their right to execute and implement DPOAs. People addicted to drugs and committed to state custody on a finding of “uncontrollable desire for [the] use or consumption [of drugs],” 18 V.S.A. 8401-8402, do not lose their right to implement DPOAs. The only group of people who are not entitled to full implementation of their DPOAs under 14 V.S.A. 3451 et seq. are people with mental illness.
There is no doubt that Act 114 is discriminatory: “the Act…facially single[s] out the handicapped and appl[ies] different rules to them. Thus the discriminatory intent and purpose of the Act …[is] apparent on [its] face. Whether such discrimination is legal or illegal remains to be seen, but there can be no doubt that the Act [is] discriminatory.” Bangerter v. Orem , 46 F.3d 1491, 1500 (10 th Cir. 1995).
Similarly, in this case, discrimination on the basis of commitment status is discrimination on the basis of disability under the ADA. People with mental disabilities or who are regarded as being mentally disabled are subject to commitment, so appellants’ argument that they are discriminating on the basis of commitment status amounts to an argument that they are discriminating against a sub-group of people with mental disabilities. The State under the ADA need not disadvantage all persons with a certain disability in order to discriminate: if every person disadvantaged by a certain enactment, such as Act 114, is necessarily a person with a certain disability, the act is discriminatory on the basis of disability. This is especially true in the case of laws such as Act 114, which are discriminatory on their face, as opposed to laws that have disparate impact.
This was confirmed in Doe v. Stincer, 990 F.Supp. 1427 (S.D.Fla. 1997), where a statute requiring facilities to give former patients unfettered access to their medical treatment records but which permitted facilities to deny access to mental health treatment records, was held to violate the ADA because it operated to “impose or apply eligibility criteria that screen out or tend to screen out an individual with a disability or any class of individuals with disabilities from fully and equally enjoying any service, program, or activity, unless criteria can be shown to be necessary for the provision of the service, program or activity being offered.” Id. At 1432.
In both Doe and this case, legislatures enacted broad rights for state citizens, then created exclusions to those rights for people receiving psychiatric treatment. In both, the exclusions were justified as protections in the best interests of the disadvantaged class. In both, available research did not support dire predictions of harm to psychiatric patients if they were allowed to exercise their rights in the same way as other citizens. In both, there is at least some evidence that citizens in other states exercise similar rights without disaster or difficulty.
In a recent case, this Court found that people residing in a halfway house were people with disabilities under the ADA because they had to meet certain statutory criteria before being admitted to the program. Regional Economic Community Action Program v. City of Middletown, 281 F.3d 333, 345 (2nd Cir. 2002). If the state in that case had argued that it was not discriminating against substance abusers, but only those individuals with substance abuse who happened to meet the legislative criteria, it would not have succeeded. Appellants here should also fail. The classification “people subject to Act 114” contains within it only people who have mental disabilities that substantially limit their major life activities, in the same way that the classification “methadone users” contains within it only people whose addiction substantially limits their major life activities.
Act 114 screens out people with disabilities, and imposes on them burdens not imposed on non-disabled people; this clearly constitutes discrimination under the ADA. Ellen S. v. Florida Board of Bar Examiners, 859 F.Supp.1489, 1494 (S.D.Fla. 1994)(finding defendants discriminated against qualified applicants with disabilities by using screening requirements that placed additional burdens on them because of their disability); Guckenberger v. Boston University, 947 F.Supp. 106, 137 (D.Mass. 1997)(same).
A. The Affirmative Defense of Fundamental Alteration Is Inapplicable in Cases Where the Plaintiff Does Not Seek a Reasonable Accommodation
Appellants claim that requiring them to honor the DPOAs of people under orders of treatment would “fundamentally alter their program.” In the first place, the "program or benefit" from which appellees have been excluded is not the state’s mental health program, but the benefit of being able to implement a DPOA in the same way as other Vermont citizens. Including appellees in this program—as was done in the decade between 1987 and 1997—was hardly a fundamental alteration to objectives of the statute.
In addition, appellants misunderstand the nature of the affirmative defense of "fundamental alteration." As is clear from the regulations and case law, "fundamental alteration" and "undue hardship" are affirmative defenses that can be raised only when an individual plaintiff requests a reasonable accommodation from a defendant.
The Department of Justice, charged with promulgating regulations to implement Title II of the ADA, permits the “fundamental alteration” defense when a disabled person asked for a reasonable modification of a public entity’s services, programs or activities, 28 C.F.R. 35.130(b)(7). (See footnote 3) This reference to “fundamental alteration” is the only time that this defense appears in the Department of Justice’s regulations implementing the ADA. In Title II cases in this Circuit, “fundamental alteration” appears only in the context of cases about reasonable modification. See, e.g., Garcia v. State of New York Health Sciences Center, 280 F.3d 98, 109 (2nd Cir. 2001)(referring to “Title II’s requirement that a state make reasonable modifications in its programs, services or activities for a ‘qualified individual with a disability’ unless that state can establish that the modification would work a fundamental alteration in the nature of the program, service or activity”). See also Borkowski v. Central Valley School District 63 F.3d 131 (2nd Cir. 1995); Staron v. McDonald’s Corp., 51 F.3d 353, 356 (2nd Cir. 1995).
Act 114 is not generally applicable. It applies only and specifically to people with psychiatric disabilities, and its provision restricting their advance directives is aimed only at them. When a statute facially singles out a group of disabled people and applies different standards to them, plaintiffs who challenge the statute are alleging intentional discrimination, regardless of the motivation of those who passed the statute. United Auto Workers v. Johnson Controls, 499 U.S. 187 (1991). Since a facially discriminatory statute or ordinance cannot be “reasonably modified” the fundamental alteration defense is inapplicable.
As to the first argument, since many people subject to Act 114 are not hospitalized,
Appellants cannot meet their burden of proof that honoring DPOAs will increase the length of stay, let alone predict by how long predict patients’ stays would be increased (a significant datum that appears nowhere in the record or in appellants’ brief), because the impact on length of stay is entirely speculative. First, the research on the impact of treatment refusal on length of stay is equivocal at best, see pp. 23-26 infra. Second, there is a substantial distinction between treatment choices made by an institutionalized individual in the moment that medication is offered and a decision for the future, made by a competent person, embodied in a legal document.
Finally, it is not at all clear that an increased length of stay would, in fact, constitute a “fundamental alteration” in the State’s mental health program. State mental health agencies argued this proposition strenuously twenty years ago when the right to refuse treatment was first litigated. They failed to convince courts then that recognizing the right would fundamentally alter the mental health system or undermine care and treatment. See Rogers v. Commissioner of Mental Health, 458 N.E. 2d 308 (Mass.1983), Rivers v. Katz, 495 N.E. 2d 337 (N.Y. 1986), State ex rel. Jones v. Gerhardstein, 416 N.W.2d 883 (Wisc. 1987). The skepticism was well founded. Later empirical research showed that the right to refuse treatment had little if any impact on the operation of the institutions or the state mental health systems.
Because of the concern about the impact of granting patients the right to refuse treatment on mental health systems, there was significant research on the topic. That research is highly equivocal. As Prof. Clayton observed fifteen years ago, “the evidence about the impact of treatment refusal on length of hospitalization is conflicting,”
In addition, just because people refuse medication does not mean that they languish untreated. Other treatments are available in both hospital and community settings. And just because people are treated does not mean they are discharged from institutions. In fact, case law and research suggest that people who are involuntarily medicated often remain hospitalized.
Equating research regarding medication refusal in institutions with any kind of prediction about the results of honoring DPOAs is problematic. One of the major advantages of DPOAs is precisely that they permit an individual to make a thoughtful decision about treatment in advance of the crisis of hospitalization. Thus, treatment choices in DPOAs cannot be equated with spur of the moment refusals by someone in an acute, possibly debilitated and dysfunctional state. Rather, they represent the carefully considered wishes of a competent individual, reduced to writing and witnessed by two individuals. Any effort to equate the consequences of treatment refusal by hospitalized individuals and the consequences of treatment refusal pursuant to a DPOA, must be viewed skeptically and any conclusions analyzed with care.
If anything, the DPOA format is particularly well suited for people with psychiatric disabilities, who can make predictions regarding what they would or would not want in the way of treatment based on past experience. Because psychiatric disability is cyclical and intermittent people with psychiatric disability are well situated to execute advance directives, anticipating what might happen in the next crisis on the basis of their experience in the last. It is also acknowledged by the psychiatric profession that for some people, no medications work; for many others, some medications work and others do not, and that some medications have idiosyncratic or negative effects on particular individuals. A DPOA can be a useful means of ensuring that lessons from the experience of what works and what does not will be implemented by treatment professionals if the individual is incompetent.
Although there is no support for the proposition that honoring DPOAs would lead to longer lengths of stay, even if it did, this could be a rational choice for competent people to make, given the risks, intrusiveness, and side effects of psychotropic medication. See Toraty v. Mental Hygiene Legal Services (In re Joseph O.), 666 N.Y.S.2d 322, 324 (N.Y.App.Div. 1997)(citing Joseph O’s clearly expressed desire to remain institutionalized if that was the cost of refusing medication). See also J.S. v. City of Newark, 652 A.2d 265 (N.J. Super. 1993)(patient with tuberculosis retained his right to refuse medication “with numerous side effects” even if it led to his continued confinement). As the highest court in Massachusetts observed, “since it is the patient who bears the risks as well as the benefits of treatment by antipsychotic drugs, and must suffer the consequences of any treatment decision, the patient has the right to make that decision,” Rogers v. Commissioner of Mental Health, 458 NE 2d 308, 316 (1983). “Even if the patient’s choice will not achieve the restoration of the patient’s health, or will result in longer hospitalizations, that choice must be respected.” Id. at n. 15.
Amici agree that concern over length of stay is valid, but question whether, in the absence of any kind of evidence that honoring DPOAs would extend length of stay, or for how long, defendants can meet their burden of showing fundamental alteration to the mental health system. Unfortunately, long stays by some patients are not uncommon; they hardly constitute “fundamental alterations” of the state’s mental health program. The question here is whether permitting clients who have thought through their own treatment carefully enough to implement a legal document naming an individual to represent them and protect their preferences would “fundamentally alter” the mental health treatment system. If all that defendants can muster to support their argument is a single conclusory and inadequate affidavit, a program of broad exclusion of all patients in this group from implementation of their DPOAs cannot stand.
Respectfully submitted,
Amici NAPAS, Bazelon Center, NARPA
By their attorneys,
________________________
Susan Stefan
Robert D. Fleischner
Center for Public Representation
22 Green Street
Northampton, MA 01060
(413) 586-6024
I hereby certify that two copies of the above document were served upon Bridget C. Asay, Assistant Attorney General, State of Vermont, Office of the Attorney General, 109 State Street, Montpelier, VT 05609-1001, Paul M. Smith, Jenner & Block, LLC, 601 Thirteenth Street, N.W., Washington, DC 2005, Whitman Smith, Mickenberg, Dunn, Kochman, Lachs & Smith, 28 Pine Street, P.O. Box 406, Burlington, VT 05609-1001, Beth A. Danon, Vermont Protection & Advocacy, 141 Main Street, Suite 7, Montpelier, VT 05602, John Townsend Rich, Shea & Gardner, 1800 Massachusetts Avenue, N.W., Washington, D.C. 20036 by first class mail on July 2, 2002,
______________________________
Robert D. Fleischner
I hereby certify that this brief was prepared using MS Word and that the program’s word count tool indicates that the brief (not including the cover page, tables, the corporate disclosure statement and the certificates of counsel) is 6723 words.
________________________________
Footnote: 2
Footnote: 3
Footnote: 4
Footnote: 5
Footnote: 6
Footnote: 7
Footnote: 8
Footnote: 9
Footnote: 10
Footnote: 11
Footnote: 12
F. Cournos, K. McKinnon, and B. Stanley, supra n.8 (half the patients in both the treatment compliant and forcibly medicated groups remained continuously institutionalized for the two-year period of the study).
| Attached Files: | ||||
| ||||


